Gregory Solz, RQAP-GCP, CQM, CQA

Gregory Solz has a diverse work experience in quality assurance and compliance roles. Gregory is currently serving as the Vice President / Management Representative Quality (GxP) at OncoSec since March 2018. Gregory previously held the position of Executive Director / Management Representative of Quality at OncoSec Medical Incorporated from April 2018 to January 2022.

Prior to that, Gregory worked at Orexigen Therapeutics as the Sr. Director, Clinical Quality Compliance from June 2016 to April 2018. Gregory also served as the Director of Quality Assurance at Neothetics from January 2014 to June 2016, where they were responsible for compliance/audit activities and building quality systems.

Gregory had a long tenure at Therapeutics, Inc. where they held the position of Director of Quality Assurance from an unknown date to 2015. Before that, they worked as the Manager, QA (U.S.) at Chiltern International from an unknown date to 2006. Gregory also served as the Management Representative / U.S. Quality Assurance at Inovio Pharmaceuticals Inc. from an unknown date to 2003.

Throughout their career, Gregory has also worked in various quality assurance roles at Magellan Laboratories, Elan Pharmaceuticals, and General Dynamics.

Gregory Solz has a solid background in quality assurance, compliance, and management representation across multiple industries.

Gregory Solz obtained a Bachelor of Science degree in Engineering/Industrial Management from San Diego State University, where they studied from 1990 to 1994. In addition to their degree, they hold certifications in RQAP-GCP, CQA, and CQM, although the specific institution and dates of obtaining these certifications are not provided. There is no information available regarding any other formal education or degrees obtained by Gregory Solz.